Aflibercept, Ranibizumab Not Cost-Effective Vs. Bevacizumab
Not cost-effective for diabetic macular edema unless prices decrease considerably
Risk of S. aureus Bacteremia Up in Patients on Glucocorticoids
Community-acquired Staphylococcus aureus bacteremia risk rose along with the dosage
Chemo Ups Metabolic Syndrome Risk in Early-Stage Breast Cancer
Significantly increased risk of metabolic syndrome components and overall MetS score
Faster Results for Experimental Rx in Chronic Migraine
TEV-48125 begins working within three to seven days
Women With A-Fib Less Likely to Receive Oral Anticoagulants
Even though they have a higher stroke risk from the condition than men
Ixekizumab Efficacious for Psoriasis Over 60 Weeks
Four in five patients saw at least a 75 percent improvement in symptoms
California’s Right-to-Die Law Now in Effect
Move raises percentage of terminally ill patients in United States who will now have this option
Review Finds Antidepressants Ineffective in Children, Teens
Medications were seen as mostly ineffective and sometimes risky in these age groups
ERs May Be Overprescribing Antibiotics for Possible STIs
Three in four tests for gonorrhea, chlamydia came back negative
No Significant Weight Change With Adjuvant Sulfonylureas
Addition maintains glycemic control without weight change among patients with T2DM taking metformin
